Viking Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Viking Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2014 to Q3 2024.
  • Viking Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 111M shares, a 11.4% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 111M +11.4M +11.4% Sep 30, 2024 10-Q 2024-10-23
Q2 2024 111M +10.8M +10.8% Jun 30, 2024 10-Q 2024-07-24
Q1 2024 110M +30.9M +39% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 100M +21.9M +27.9% Dec 31, 2023 10-Q 2024-10-23
Q3 2023 100M +23.3M +30.4% Sep 30, 2023 10-Q 2023-10-25
Q2 2023 100M +23.3M +30.4% Jun 30, 2023 10-Q 2023-07-26
Q1 2023 79.3M +1.95M +2.51% Mar 31, 2023 10-Q 2023-04-26
Q4 2022 78.3M +8.86K +0.01% Dec 31, 2022 10-K 2024-02-07
Q3 2022 76.7M -1.55M -1.98% Sep 30, 2022 10-Q 2022-10-26
Q2 2022 76.7M -1.5M -1.92% Jun 30, 2022 10-Q 2022-07-27
Q1 2022 77.4M +196K +0.25% Mar 31, 2022 10-Q 2022-04-27
Q4 2021 78.2M +5.03M +6.87% Dec 31, 2021 10-K 2023-02-10
Q3 2021 78.2M +5.31M +7.29% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 78.2M +5.43M +7.47% Jun 30, 2021 10-Q 2021-07-28
Q1 2021 77.2M +4.62M +6.36% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 73.2M +802K +1.11% Dec 31, 2020 10-K 2022-02-09
Q3 2020 72.9M +666K +0.92% Sep 30, 2020 10-Q 2020-10-28
Q2 2020 72.8M +585K +0.81% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 72.6M +535K +0.74% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 72.4M +672K +0.94% Dec 31, 2019 10-K 2021-02-17
Q3 2019 72.3M +971K +1.36% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 72.2M +11.5M +19% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 72M +21.1M +41.4% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 71.7M +35.9M +100% Dec 31, 2018 10-K 2020-02-26
Q3 2018 71.3M +42.8M +150% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 60.7M +33M +119% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 50.9M +27M +113% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 35.8M +15M +72% Dec 31, 2017 10-K 2019-03-13
Q3 2017 28.5M +8.6M +43.2% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 27.7M +8.42M +43.7% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 23.9M +14.2M +147% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 20.8M +11.1M +115% Dec 31, 2016 10-K 2018-03-07
Q3 2016 19.9M +10.1M +103% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 19.3M +9.49M +97% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 9.68M +3.68M +61.4% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 9.68M +3.68M +61.4% Dec 31, 2015 10-K 2017-03-21
Q3 2015 9.78M Sep 30, 2015 10-Q 2015-11-05
Q2 2015 9.78M Jun 30, 2015 10-Q 2015-08-14
Q1 2015 6M Mar 31, 2015 10-Q 2015-06-12
Q4 2014 6M Dec 31, 2014 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.